Literature DB >> 23249847

Cognitive training for Hong Kong Chinese with schizophrenia in vocational rehabilitation.

D W K Man1, K M Law, R C K Chung.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23249847

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


× No keyword cloud information.
  5 in total

1.  Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence.

Authors:  Marco Solmi; Giovanni Croatto; Giada Piva; Stella Rosson; Paolo Fusar-Poli; Jose M Rubio; Andre F Carvalho; Eduard Vieta; Celso Arango; Nicole R DeTore; Elizabeth S Eberlin; Kim T Mueser; Christoph U Correll
Journal:  Mol Psychiatry       Date:  2022-08-23       Impact factor: 13.437

2.  Evaluation of a computer-assisted cognitive remediation program for young people with psychosis: A pilot study.

Authors:  Andrew M H Siu; Rita S H Ng; Magdalene Y C Poon; Catherine S Y Chong; Clara M W Siu; Sally P K Lau
Journal:  Schizophr Res Cogn       Date:  2020-09-11

Review 3.  Interventions for obtaining and maintaining employment in adults with severe mental illness, a network meta-analysis.

Authors:  Yvonne B Suijkerbuijk; Frederieke G Schaafsma; Joost C van Mechelen; Anneli Ojajärvi; Marc Corbière; Johannes R Anema
Journal:  Cochrane Database Syst Rev       Date:  2017-09-12

4.  Utilization of psychiatric rehabilitation services and influencing factors among people with psychotic disorders in rural communities of Guangxi, China.

Authors:  Hongye Luo; Edward B McNeil; Qiming Feng; Hongheng Li; Qiang Chen; Xianjing Qin; Jun Feng; Sawitri Assanangkornchai
Journal:  Int J Ment Health Syst       Date:  2018-04-17

5.  A Multimodal Speech-Gesture Training Intervention for Patients With Schizophrenia and Its Neural Underpinnings - the Study Protocol of a Randomized Controlled Pilot Trial.

Authors:  Lydia Riedl; Arne Nagels; Gebhard Sammer; Benjamin Straube
Journal:  Front Psychiatry       Date:  2020-03-06       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.